COVID-19 diagnostics: Thermo Fisher Scientific collaborates with Artificial

News • Testing solution

COVID-19 diagnostics: Thermo Fisher Scientific collaborates with Artificial

Thermo Fisher Scientific and Artificial have announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform. The integration will result in increased testing throughput and support global healthcare initiatives.

As part of the collaboration, Artificial will provide access to its aLab Suite software, designed to seamlessly integrate with Thermo Scientific Momentum Workflow software and robotics hardware. This will form part of the COVID-19 Testing Platform that will enable laboratories to quickly upscale COVID-19 testing volumes to help reduce the spread of the disease and restore economies and communities. The aLab Suite software facilitates the dynamic scheduling of protocol runs with batch optimizations to maximize the number of tests run. In addition, manual system set-up steps associated with Momentum process execution can be coordinated using aLab digital assistants to reduce the need for user input. Furthermore, the use of aLab assistant’s digital twin of a COVID-19 testing system to guide lab technicians on where, when and how to load system consumables will reduce errors associated with manual tasks, ensuring sample safety and integrity and increasing system productivity.

“Laboratories performing COVID-19 testing continue to face the combined challenges of rapidly scaling workflows to meet the demands of communities while ensuring the accuracy and reproducibility of results,” said Hansjoerg Haas, senior director and general manager, laboratory automation, Thermo Fisher Scientific. “This collaboration enables biopharma and contract services companies to both simplify their lab technicians’ interactions with automated systems and more efficiently coordinate the use of their multiple Momentum automated systems, increasing productivity and minimizing user intervention to meet industry needs.”

“Artificial’s aLab Suite is a great addition to Thermo Fisher’s standardized COVID-19 Testing Platform solution in further enabling COVID-19 testing laboratories to easily and quickly scale their operations to meet the current demands,” said David Fuller, CEO of Artificial. “Our partnership with Thermo Fisher Scientific represents an exciting opportunity to improve COVID-19 testing throughput and further develop the aLab Suite to address the pain points of the life sciences market.”

As part of the partnership, Thermo Fisher Scientific will utilize its extensive experience across life sciences to provide feedback on aLab Suite functionalities and capabilities to contribute to future product requirements and system specifications.

To find out more about the solutions, please visit Momentum Workflow software and aLab Suite software.

Source: Thermo Fisher Scientific

24.03.2021

Read all latest stories

Related articles

Photo

Interview • Urinalysis for Covid-19 diagnostics

Automation to relieve pandemic pressure from laboratories

To provide a solution for the challenges of the coronavirus pandemic, Beckman Coulter recently launched the DxU Iris, a urinalysis solution which aims to improve lab workflows.

Photo

News • Microfluidics and electrochemical transduction

Paper-based device for rapid diagnosis of lung diseases

A new device that combines microfluidics on paper, electrochemical transduction and immunoassays on magnetic nanoparticles is useful for easy and rapid diagnosis of lung diseases.

Photo

Sponsored • 100th DxA Automation System installed

Automation reimagines laboratory diagnostics service

San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman…

Related products

Sarstedt · Tempus600 Vita

Sample Logistics

Sarstedt · Tempus600 Vita

SARSTEDT AG & CO. KG
Beckman Coulter · DxA 5000

Automation

Beckman Coulter · DxA 5000

Beckman Coulter Diagnostics
Beckman Coulter · DxA 5000 Fit

Automation

Beckman Coulter · DxA 5000 Fit

Beckman Coulter Diagnostics
Beckman Coulter · DxM Autoplak Automation

Automation

Beckman Coulter · DxM Autoplak Automation

Beckman Coulter Diagnostics
Genrui · PA120

Immunoassays

Genrui · PA120

Genrui Biotech Inc.
Improve Medical · Automatic Biosafety Decapper

Sample Processing

Improve Medical · Automatic Biosafety Decapper

Improve Medical
Subscribe to Newsletter